What we have learned about sleep disorders and psychosis after nearly two centuries of Parkinson's disease. Summary and conclusions.
Fernandez
Hubert H
HH
Department of Neurology, University of Florida, Gainesville, FL, USA. fernandez@neurology.ufl.edu
D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use; D001921:Brain / Q000503:physiopathology; D004298:Dopamine / Q000502:physiology; D004347:Drug Interactions; D006801:Humans; D010300:Parkinson Disease / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D011605:Psychoses, Substance-Induced / Q000175:diagnosis / Q000503:physiopathology; D011618:Psychotic Disorders / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use; D020919:Sleep Disorders, Intrinsic / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology
D000978:Antiparkinson Agents; D011619:Psychotropic Drugs; D004298:Dopamine